Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Defining Retroviruses
-
1. An introduction to retroviruses: replication strategy and genetics
- Dr. Jonathan Stoye
-
2. Bovine leukemia virus
- Prof. Arsene Burny
- Dr. Lucas Willems
- The First Human Retroviruses
-
3. The discovery of human retroviruses and how they cause disease
- Prof. Robert Gallo
- HIV - Peculiarities of its Genome
-
4. HIV: peculiarities of its genome
- Dr. George Pavlakis
- HIV Transmission, Epidemiology and Public Health/Prevention Issues
-
5. HIV/AIDS epidemiology, transmission, and risk factors
- Prof. William Blattner
-
6. HIV prevention and public health issues: a global perspective
- Prof. Sten H. Vermund
- How HIV causes AIDS
-
7. How HIV causes disease 1: identification and characterization of HIV
- Prof. Bruce Walker
-
8. How HIV causes disease 2: immune responses to HIV infection
- Prof. Bruce Walker
- HIV Therapy - Now and the Future
-
9. HIV therapy: taking advantage of progress
- Prof. Paul Volberding
-
10. HIV cure: harnessing innate and adaptive strategies
- Prof. Luis Montaner
- Archived Lectures *These may not cover the latest advances in the field
-
11. The first human retroviruses: the human T lymphotropic viruses (HTLVs)
- Prof. William Hall
-
12. HIV preventive vaccines
- Prof. Andrew McMichael
-
13. HIV/AIDS in the developing world: what can we do?
- Dr. Joseph O'Neill
-
15. Antiretroviral therapy 2007, new concepts and lessons learned
- Prof. Robert Redfield
-
16. What to do in therapy in the face of HIV drug resistance?
- Prof. Mark Wainberg
-
17. Viral reservoirs, latency and mechanisms of HIV persistence
- Prof. Robert Siliciano
-
18. HIV preintegration complexes
- Prof. Lee Ratner
-
19. The discovery of ATL field expansion in 40 yrs
- Prof. Junji Yodoi
Printable Handouts
Navigable Slide Index
- Introduction
- Scope of the problem
- Estimated number of people living with HIV
- Estimated number of deaths due to AIDS
- A global view of HIV infection
- HIV/AIDS and development
- Number of people living with HIV by region
- Percent of HIV infected adults who are female
- HIV prevalence among antenatal clinic attendees
- Proportion of HIV infection in population groups
- HIV prevalence: men who have sex with men
- Context of development
- Population trends (1)
- Population trends (2)
- Cancer in developing world (1)
- Cancer in developing world (2)
- Resources - 1998 per capita health expenditures
- Resources - 2001 World Bank estimates
- Access to clean water
- Hunger is a leading cause of death
- Impact of the pandemic
- Impact of AIDS on life expectancy
- Impact of AIDS on under-five mortality rates
- Reduction in African agricultural labor force
- 25 years of AIDS
- Impact of orphanhood on school attendance
- Knowledge about HIV among young males
- Why do anything?
- Quote by Elie Wiesel
- Quote by Albert Schweitzer
- Quote by Gordon Brown
- U.S. response
- Enlightened self interest
- UN security council resolution - 2000
- Quote by Peter Piot
- HIV/AIDS as a national security issue
- What is being done?
- Public funding
- Sources of estimated and projected funding
- DAC members' official development assistance
- Research
- NIH HIV/AIDS research funding
- UK medical research council expenditure
- Annual public sector investment
- Private sector vaccine research
- Private philanthropy
- Private philanthropy for global HIV/AIDS
- Impact of current efforts
- Progress towards declaration of commitment
- Youth who identify ways to prevent HIV infection
- HIV positive women on antiretroviral prophylaxis
- Infants born to HIV infected mothers
- Rates of antiretroviral therapy
- Comparison of 2003 and 2005 data
- What can health professionals/scientists do?
- Support good public policy
- Pay attention to quality medical care
- Raise public consciousness
- Opportunities for direct service
- Non governmental organizations (NGOs)
- Public sector service
- Academic institutions
- Conclusion
Topics Covered
- Global HIV epidemiology
- Scope of the problem
- The context of development: poverty, displacement, other health concerns
- Necessity of responding
- What is being done?
- Impact of current efforts
- Unique role for health professionals and scientists
Talk Citation
O'Neill, J. (2007, October 1). HIV/AIDS in the developing world: what can we do? [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/KVCU2446.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Joseph O'Neill has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.